Table: Wakamoto Pharm -2015/16 parent results

Wakamoto Pharmaceutical

16/05/2016 07:00

May 16 (Reuters)-  
          Wakamoto Pharmaceutical Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to        NEXT     
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017      YEAR       
                 LATEST         YEAR-AGO        COMPANY       COMPANY     
                 RESULTS         RESULTS       FORECAST     H1 FORECAST   
  Sales           11.18           10.74          11.20          5.40      
               (+4.2 pct)      (+2.8 pct)     (+0.1 pct)     (-1.7 pct)   
  Operating      83 mln          202 mln        60 mln      loss 220 mln  
               (-59.0 pct)     (-22.0 pct)    (-27.9 pct)                 
  Recurring      124 mln         233 mln        40 mln      loss 220 mln  
               (-46.5 pct)     (-38.0 pct)    (-68.0 pct)                 
  Net            20 mln          83 mln          2 mln      loss 160 mln  
               (-75.4 pct)     (-90.1 pct)    (-90.2 pct)                 
  EPS           0.59 yen        2.40 yen       0.06 yen    loss 4.61 yen  
  Ann Div       3.00 yen        3.00 yen                                  
  -Q2 Div          NIL             NIL                                    
  -Q4 Div       3.00 yen        3.00 yen                                  
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))